Completed PHASE3 INTERVENTIONAL 2-arm NCT03460561

Peri-operative Rectus Sheath Block Versus TEA Abdominal Surgeries

Peri-operative Rectus Sheath Fentanyl-Levo Bupivacaine Infusion Versus Thoracic Epidural Fentanyl-Levo Bupivacaine Infusion in Patients Undergoing Major Abdominal Cancer Surgeries With Medline Incision

Sponsor: South Egypt Cancer Institute

Conditions Abdominal Cancer

Interventions Rectus sheath block (RSB) Thoracic epidural block (TEA)

Updated 6 times since 2018 Last updated: Mar 7, 2018 Started: Aug 1, 2016 Primary completion: Feb 20, 2018 Completion: Feb 20, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Abdominal Cancer, this trial is completed. The trial is conducted by South Egypt Cancer Institute and has accumulated 6 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Mar 2018 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

South Egypt Cancer Institute

Data source: South Egypt Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt